Physician-focused Payment Model Technical Advisory Committee

Physician-focused Payment Model Technical Advisory Committee
Name	Physician-focused Payment Model Technical Advisory Committee
Abbreviation	P-TA C
Formation	2015
Purpose	Advisory panel for model proposals under the Medicare Access and CHIP Reauthorization Act
Headquarters	Washington, D.C.
Region served	United States
Leader title	Chair
Parent organization	Centers for Medicare & Medicaid Services

Contents

Physician-focused Payment Model Technical Advisory Committee

The committee is a statutory advisory panel created to evaluate alternative payment models under the Medicare Access and CHIP Reauthorization Act. It provides independent assessments to assist the Centers for Medicare & Medicaid Services and inform policymakers including members of the United States Congress, the Department of Health and Human Services, and stakeholders such as the American Medical Association, American Hospital Association, and specialty societies like the American College of Cardiology. The panel's work connects to federal statutes such as the Medicare Access and CHIP Reauthorization Act of 2015 and interacts with programs including Medicare Shared Savings Program, Medicare Advantage, and Accountable Care Organizations.

Overview

The advisory committee evaluates proposals for physician-focused payment models and issues reports and recommendations that may influence rulemaking by the Centers for Medicare & Medicaid Services, guidance from the Department of Health and Human Services, and legislative deliberations in the United States Senate and United States House of Representatives. Members bring expertise from organizations including the National Institutes of Health, Agency for Healthcare Research and Quality, Harvard Medical School, Johns Hopkins University School of Medicine, Mayo Clinic, Cleveland Clinic, and private sector entities such as UnitedHealth Group, Aetna, Anthem, Inc., and Blue Cross Blue Shield Association. The committee's remit intersects with programs and laws like the Balanced Budget Act of 1997, Health Care Financing Administration reforms, and policy frameworks advanced by think tanks including the Brookings Institution and the Kaiser Family Foundation.

The panel was established by provisions in the Medicare Access and CHIP Reauthorization Act of 2015, enacted by the 114th United States Congress and signed by Barack Obama. Its first charter and membership selections followed consultations with officials from the Centers for Medicare & Medicaid Services, advisors with experience at the Office of Management and Budget, and representatives from professional bodies such as the American Academy of Family Physicians, American College of Physicians, American Academy of Pediatrics, and surgical societies like the American College of Surgeons. Early activity referenced demonstration programs like the Comprehensive Primary Care Initiative, the Bundled Payments for Care Improvement models, and pilot projects influenced by research from institutions such as RAND Corporation and Columbia University Irving Medical Center.

The committee reviews physician-focused payment model proposals submitted by stakeholders including academic medical centers, specialty societies, integrated delivery networks, and private payers. It evaluates models against criteria informed by legislation and guidance from entities such as the Government Accountability Office, the Office of Inspector General of the Department of Health and Human Services, and the Congressional Budget Office. The committee issues technical letters and recommendations, conducts public meetings compliant with the Administrative Procedure Act, and solicits input from organizations like the Consumer Financial Protection Bureau and advocacy groups including Families USA and the Association of American Medical Colleges. Its analyses draw on methods developed by researchers at Johns Hopkins Bloomberg School of Public Health, University of Michigan School of Public Health, and statistical frameworks used by Centers for Medicare & Medicaid Services actuaries.

The committee has evaluated proposals that relate to specialty-focused models from the American College of Cardiology, primary care models supported by Patient-Centered Primary Care Collaborative, oncology models proposed by organizations like the American Society of Clinical Oncology, and orthopedics bundled models promoted by the American Academy of Orthopaedic Surgeons. Its recommendations have influenced testing of models aligned with episodes-of-care initiatives such as those piloted by CMMI and have been cited during policy debates involving the Medicaid Innovation Accelerator Program, Physician Quality Reporting System, and the transition to value-based payment delineated by leaders at Dartmouth Institute and Institute for Healthcare Improvement. Legal and policy scholars from Georgetown University Law Center and Harvard Kennedy School have analyzed the committee's advisory opinions in papers and testimony.

Critics have raised concerns about potential conflicts of interest related to members' affiliations with private payers like Centene Corporation and provider systems such as Kaiser Permanente, and with industry stakeholders including Johnson & Johnson and Pfizer. Academic commentators at University of California, Berkeley, New York University School of Law, and advocacy organizations including Public Citizen have questioned transparency, representativeness, and the degree to which recommendations translate into equitable outcomes for Medicare beneficiaries represented by groups like the National Senior Citizens Law Center. Congressional oversight hearings involving members of the Senate Finance Committee and the House Ways and Means Committee have examined the committee's role relative to broader health policy objectives pursued by administrations such as those led by Donald Trump and Joe Biden.